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1. INTRODUCTION {#jcla22989-sec-0005}
===============

Sigma (*σ*) metric was first introduced into clinical laboratories by David Nevalainen[1](#jcla22989-bib-0001){ref-type="ref"} in 2000. The practice of using the *σ* to improve clinical laboratory quality has been in place for nearly two decades.[2](#jcla22989-bib-0002){ref-type="ref"} Sigma metric has become a useful tool to monitor quality indicators,[1](#jcla22989-bib-0001){ref-type="ref"} to assess the analytical quality of assays,[3](#jcla22989-bib-0003){ref-type="ref"}, [4](#jcla22989-bib-0004){ref-type="ref"} to set quality control rules,[5](#jcla22989-bib-0005){ref-type="ref"}, [6](#jcla22989-bib-0006){ref-type="ref"}, [7](#jcla22989-bib-0007){ref-type="ref"}, [8](#jcla22989-bib-0008){ref-type="ref"} to describe assay analytical performance for external quality assessment participants,[9](#jcla22989-bib-0009){ref-type="ref"} and to help manufacturers choose product requirements.[10](#jcla22989-bib-0010){ref-type="ref"} Analytical quality of assays is quantitatively estimated as a sigma metric based on 3 parameters: allowable total error (TEa), bias, and imprecision. The TEa from various sources, such as the Clinical Laboratory Improvement Amendments (CLIA), the College of American Pathologists (CAP), Reference Institute for Bioanalytics (Rilibak), the Royal College of Pathologists of Australasia (RCPA), and the China National Center for Clinical Laboratories (NCCL) external quality assessment goals, is associated with significantly different Sigma metrics for the same assay.[8](#jcla22989-bib-0008){ref-type="ref"}, [11](#jcla22989-bib-0011){ref-type="ref"} Thus, laboratories have to take into account which TEa specification is most appropriate initially.

Imprecision is usually presented as the standard deviation (SD) or coefficient of variation (CV). CV (SD) and bias often vary with the concentration of analytes, so the *σ* computed at different QC concentration levels could be quite different from one another.[12](#jcla22989-bib-0012){ref-type="ref"} Previous studies have reported that individual assays\' biases were calculated by comparing their mean with the statistical target mean in external quality assessment (EQA) survey reports,[13](#jcla22989-bib-0013){ref-type="ref"}, [14](#jcla22989-bib-0014){ref-type="ref"} but the statistical target mean was derived from statistical results, which did not have measurement traceability. Additionally, if the concentration of IQC materials differed significantly from that of EQA samples, the *σ* calculation may not represent the optimal quality of the analytes. On the other hand, the target means in trueness verification proficiency testing was determined by the reference methods. Therefore, the bias and imprecision from this approach were more convincing.[12](#jcla22989-bib-0012){ref-type="ref"} Laboratories using commercial quality control could upload the IQC data to the inter‐laboratory comparison database and compare these data with the target mean of the peer group to calculate bias and CV. The internal quality control data inter‐laboratory comparison‐based approach has been shown to be a convenient and reliable method among clinical laboratories. Xinqi Cheng et al[15](#jcla22989-bib-0015){ref-type="ref"} introduced two approaches to compute bias and CV for *σ* evaluation, using a proficiency testing (PT) or an internal quality control (IQC)‐based approach. Herein, we take similar approaches.[1](#jcla22989-bib-0001){ref-type="ref"} For the trueness verification proficiency testing (TPT)‐based approach, bias was calculated by comparing the measured mean with the target mean derived from the measured results of the reference measurement procedure provided by the China National Center for Clinical Laboratories (NCCL), and the CV was calculated by testing the analytes five times daily for 3 days for each TPT sample according to the instructions from the Chinese NCCL[2](#jcla22989-bib-0002){ref-type="ref"}; for the internal quality control data inter‐laboratory comparison (IQC)‐based approach, bias was calculated by comparing the measured mean with the target mean of the global peer group, and CV was calculated with the IQC results. Based on both approaches, the bias and CV of the analyte could be acquired simultaneously at the same concentration, rather than being synthetically calculated at different concentrations. We introduced this study to compare both approaches for bias and CV calculations and to determine the effects of these approaches on *σ* evaluation at two TEa specifications.

2. MATERIALS AND METHODS {#jcla22989-sec-0006}
========================

2.1. Materials {#jcla22989-sec-0007}
--------------

Nineteen assays were tested using the manufacturer\'s original reagents and calibrators on the Siemens Advia 2400 system (Siemens Healthcare Diagnostics Inc) in Beijing Tsinghua Changgung Hospital. The reference method/material traceability of the assays is shown in Table [1](#jcla22989-tbl-0001){ref-type="table"}. The trueness verification proficiency testing (TPT) samples (including Metabolites and Total Protein/Electrolyte/Enzymes/Lipids trueness verification proficiency testing samples) for nineteen analytes were provided by China National Center for Clinical Laboratories (NCCL) in 2018. The nineteen analytes of Metabolites and Total Protein/Electrolyte/Enzymes/Lipids TPT samples were GLU, UN, CREA, UA, TP/Na, K, Ca, Mg, Cl/ALT, AST, GGT, LDH, CK, AMY, ALP/TC, and TG. The internal quality controls were the Bio‐Rad (Bio‐Rad Laboratories, Inc) Liquid Assayed Multiqual controls (Lot No. 45792/45793).

###### 

Methods, units, traceability of the analytes on the Siemens Advia 2400 analyzer and number of laboratories included in each instrument peer group for the trueness verification proficiency testing (TPT) program of the Chinese NCCL, and the number of laboratories included in the Bio‐Rad IQC global peer group reports

  Analytes[a](#jcla22989-note-0002){ref-type="fn"}   GLU             UN                             CREA                    UA                                         TP                        Na                                      K                                       Ca                                           Mg                  Cl
  -------------------------------------------------- --------------- ------------------------------ ----------------------- ------------------------------------------ ------------------------- --------------------------------------- --------------------------------------- -------------------------------------------- ------------------- ----------------------------
  Methods                                            Hexokinase      Urease, UV                     Enzymatic               Uricase, colorimetric                      Biuret                    ISE indirect                            ISE indirect                            Arsenazo III                                 Xylidyl blue        ISE indirect
  Units                                              mmol/L          mmol/L                         µmol/L                  µmol/L                                     g/L                       mmol/L                                  mmol/L                                  mmol/L                                       mmol/L              mmol/L
  Reference method traceability                      NA              CDC‐R eference method          IFCC‐Reference method   CDC candidate Reference method (uricase)   Biuret Reference method   CDC Flame photometry reference method   CDC Flame photometry reference method   Inductively coupled atomic emission method   Atomic absorption   NIST coulometric reference
  Reference Material Traceability                    NIST SRM 965a   NIST SRM 912a, NIST SRM 909b   IRMM/IFCC‐4             NIST SRM 913a, NIST SRM 909                NIST SRM 927              NIST SRM 909b                           NIST SRM 909b                           NIST SRM 915, NIST SRM 90                    NIST SRM 929        Method NIST SRM 919
  Number of laboratories for NCCL TPT                241             241                            276                     246                                        318                       320                                     320                                     318                                          292                 319
  Number of laboratories for Bio‐Rad IQC             35              17                             13                      40                                         40                        50                                      50                                      29                                           44                  49
  Number of IQC data points                          1695            507                            653                     2096                                       2190                      2538                                    2529                                    1086                                         2052                2404

  Analytes[a](#jcla22989-note-0002){ref-type="fn"}   ALT                              AST                              GGT                               LDH                             CK                      AMY                      ALP                                 TC                                              TG
  -------------------------------------------------- -------------------------------- -------------------------------- --------------------------------- ------------------------------- ----------------------- ------------------------ ----------------------------------- ----------------------------------------------- --------------------
  Methods                                            UV without P5P                   UV without P5P                   G‐glutamyl‐carboxy‐nitroanilide   Lactate to pyruvate             NAC activated           G7 PNP, Blocked          PNPP, AMP Buffer, IFCC‐ Reference   Cholesterol oxidase                             Enzymatic, GPO‐PAP
  Units                                              U/L                              U/L                              U/L                               U/L                             U/L                     U/L                      U/L                                 mmol/L                                          mmol/L
  Reference Method Traceability                      IFCC‐ Reference Method at 37°C   IFCC‐ Reference Method at 37°C   IFCC‐Reference Method at 37°C     IFCC‐Reference Method at 37°C   IFCC‐Reference Method   IFCC‐ Reference Method   IFCC‐ Reference Method              CDC‐Reference Method (modified Abell‐Kendall)   Reference Method
  Reference Material Traceability                    IRMM/IFCC‐454                    NA                               IRMM/IFCC‐452                     IRMM/IFCC‐453                   IRMM/IFCC‐455           IRMM/IFCC‐456            NA                                  NIST SRM 909b                                   NIST SRM 909b
  Number of laboratories for NCCL TPT                316                              313                              383                               379                             374                     338                      380                                 362                                             324
  Number of laboratories for Bio‐Rad IQC             21                               20                               18                                13                              10                      29                       32                                  5                                               5
  Number of IQC data points                          765                              760                              577                               331                             208                     1744                     1865                                64                                              66

Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMY, amylase; AST, aspartate aminotransferase; Ca, calcium; CK, creatine kinase; Cl, chloride; CREA, creatinine; GGT, gamma‐glutamyltransferase; GLU, glucose; IQC, internal quality control; K, potassium; LDH, lactate dehydrogenase; LDL, low density lipoprotein cholesterol; Mg, magnesium; NA, none available; Na, sodium; NCCL, China National Center for Clinical Laboratories, Peking, China; TC, total cholesterol; TG, triglycerides; TP, total protein; TPT, trueness verification proficiency testing; UA, uric acid; UN, urea nitrogen.

All analytes were tested on the Siemens Advia 2400 analyzer using manufacturer\'s original reagents.
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2.2. Methods {#jcla22989-sec-0008}
------------

### 2.2.1. Sample preparation {#jcla22989-sec-0009}

All the TPT samples from the Chinese NCCL were prepared from pooled fresh human serum. Each level, with 3 separate aliquots, was frozen and stored at −70°C until shipment on dry ice to our laboratory. The samples were stored in the freezer at −70°C as soon as they were received until use. When testing, the samples were placed at room temperature for 20 minutes and then gently mixed until completely dissolved and assayed in our laboratory within 4 hours.

### 2.2.2. Bias calculation {#jcla22989-sec-0010}

For the TPT‐based approach, the target value of each level of nineteen analytes of TPT samples was assigned by the reference laboratories organized by the Chinese NCCL, following the recommended reference measurement procedures.[16](#jcla22989-bib-0016){ref-type="ref"}, [17](#jcla22989-bib-0017){ref-type="ref"}, [18](#jcla22989-bib-0018){ref-type="ref"} The aliquot of each level was measured on 3 specific days, and each aliquot was tested under repeatability condition five times referring to the procedure of CLSI EP15‐A2.[19](#jcla22989-bib-0019){ref-type="ref"} Thus, a total of 15 results were obtained for each concentration level. The average of the 15 results was considered as the laboratory‐tested value. All the results were reported to the online EQA platform developed by the Chinese NCCL ([www.nccl.org.cn](http://www.nccl.org.cn)), and a summary report of the evaluation results can also be acquired on the online EQA platform.[16](#jcla22989-bib-0016){ref-type="ref"}, [18](#jcla22989-bib-0018){ref-type="ref"} Bias was determined as (our mean − target mean)/target mean × 100%.

For the IQC‐based approach, all IQC data of nineteen analytes were included in the Bio‐Rad global comparison program and the data were collected in the clinical laboratory of Beijing Tsinghua Changgung Hospital from July 1, 2018, to December 30, 2018. The monthly (December 2018) mean, with SD and CV, was calculated. Bias was calculated as (our mean − mean of peer group)/ mean of peer group × 100%.[15](#jcla22989-bib-0015){ref-type="ref"}

### 2.2.3. Imprecision evaluation {#jcla22989-sec-0011}

Imprecision in this study was determined for each level of 19 analytes of TPT samples using the 15 results according to the formula defined in CLSI guideline EP15‐A2[19](#jcla22989-bib-0019){ref-type="ref"} for the TPT‐based approach.[18](#jcla22989-bib-0018){ref-type="ref"}

Bio‐Rad Liquid Assayed Multiqual controls were assayed daily for the nineteen analytes and calculated with the IQC results for the IQC‐based approach.

### 2.2.4. Sigma calculation {#jcla22989-sec-0012}

The two TEa requirements, USA Clinical Laboratory Improvement Amendments of 1988---CLIA \'88 (TEa~CLIA~) and People\'s Republic of China Health Industry Standard---WS/T 403‐2012 (TEa~WS/T~), were selected to calculate σ for each assay, using the equation σ = (TEa − bias)/ SD (for concentration units) and σ = (TEa% − bias%)/ CV% (for percentage units). Both TEa requirements of the 19 assays are listed in Table [2](#jcla22989-tbl-0002){ref-type="table"}. Excel 2016 software (Microsoft Corporation) was used for data analysis and graphing.

###### 

Sigma metrics computed by the trueness verification proficiency testing (TPT)‐based approach and the internal quality control data inter‐laboratory comparison (IQC)‐based approach

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Item                                             Sample number                                    Mean     Target   Bias (%)   CV (%)      TEa~CLIA~\               TEa~ws/t~ (%)                                   *σ* ~CLIA~                                      *σ* ~ws/t~
                                                                                                                                             (% \[absolute value\])                                                                                                   
  ------------------------------------------------ ------------------------------------------------ -------- -------- ---------- ----------- ------------------------ ----------------------------------------------- ----------------------------------------------- ----------------------------------------------
  GLU                                              201911                                           3.66     3.70     −1.08      0.55        10 (0.33)                7.00                                            16.22                                           10.76

  201912                                           9.24                                             9.43     −2.01    0.87       10 (0.33)   7.00                     9.18                                            5.74                                            

  45792                                            6.19                                             6.22     −0.49    1.41       10 (0.33)   7.00                     6.74                                            4.62                                            

  45793                                            19.04                                            19.35    −1.63    1.18       10 (0.33)   7.00                     7.09                                            4.55                                            

  UN                                               201911                                           5.06     4.85     4.33       1.58        9 (0.71)                 8.00                                            2.96[b](#jcla22989-note-0005){ref-type="fn"}    2.32[b](#jcla22989-note-0005){ref-type="fn"}

  201912[c](#jcla22989-note-0006){ref-type="fn"}   13.94                                            13.68    1.90     0.57       9 (0.71)    8.00                     12.46                                           10.70                                           

  45792[c](#jcla22989-note-0006){ref-type="fn"}    14.02                                            14.22    −1.35    3.61       9 (0.71)    8.00                     4.01                                            3.48                                            

  45793                                            24.51                                            25.07    −2.24    1.97       9 (0.71)    8.00                     3.43                                            2.92[b](#jcla22989-note-0005){ref-type="fn"}    

  CREA                                             201911                                           65.20    66.41    −1.82      0.80        15 (26.5)                12.00                                           16.48                                           12.73

  201912                                           728.60                                           703.38   3.59     0.60       15 (26.5)   12.00                    19.02                                           14.02                                           

  45792                                            159.02                                           161.67   −1.64    1.86       15 (26.5)   12.00                    7.18                                            5.57                                            

  45793                                            569.52                                           571.09   −0.28    1.47       15 (26.5)   12.00                    10.01                                           7.97                                            

  UA                                               201911                                           247.00   258.30   −4.37      3.00        17                       12.00                                           3.54                                            2.54[b](#jcla22989-note-0005){ref-type="fn"}

  201912                                           519.00                                           519.30   −0.06    1.00       17          12.00                    14.94                                           11.94                                           

  45792                                            366.99                                           371.93   −1.33    1.45       17          12.00                    10.81                                           7.36                                            

  45793                                            570.12                                           578.20   −1.40    1.17       17          12.00                    13.33                                           9.06                                            

  TP                                               201911[c](#jcla22989-note-0006){ref-type="fn"}   57.00    57.48    −0.84      1.60        10                       6.00                                            5.73                                            3.23

  201912                                           76.50                                            79.66    −3.97    1.60       10          6.00                     3.77                                            1.27[b](#jcla22989-note-0005){ref-type="fn"}    

  45792[c](#jcla22989-note-0006){ref-type="fn"}    55.83                                            54.51    2.43     1.90       10          6.00                     3.98                                            1.88[b](#jcla22989-note-0005){ref-type="fn"}    

  45793                                            71.83                                            70.40    2.03     1.70       10          6.00                     4.69                                            2.34[b](#jcla22989-note-0005){ref-type="fn"}    

  Na                                               201811                                           127.30   126.30   0.79       0.50        \(4\)                    4.00                                            5.00[a](#jcla22989-note-0004){ref-type="fn"}    6.42[a](#jcla22989-note-0004){ref-type="fn"}

  201812[c](#jcla22989-note-0006){ref-type="fn"}   140.80                                           140.36   0.31     0.40       \(4\)       4.00                     7.12[a](#jcla22989-note-0004){ref-type="fn"}    9.23[a](#jcla22989-note-0004){ref-type="fn"}    

  45792[c](#jcla22989-note-0006){ref-type="fn"}    141.81                                           141.89   −0.06    0.40       \(4\)       4.00                     6.88[a](#jcla22989-note-0004){ref-type="fn"}    9.85[a](#jcla22989-note-0004){ref-type="fn"}    

  45793                                            159.95                                           159.56   0.24     0.54       \(4\)       4.00                     4.15[a](#jcla22989-note-0004){ref-type="fn"}    6.96[a](#jcla22989-note-0004){ref-type="fn"}    

  K                                                201811                                           5.82     5.72     1.84       0.52        (0.5)                    6.00                                            13.17[a](#jcla22989-note-0004){ref-type="fn"}   8.00[a](#jcla22989-note-0004){ref-type="fn"}

  201812                                           5.97                                             5.93     0.62     0.34       (0.5)       6.00                     23.15[a](#jcla22989-note-0004){ref-type="fn"}   15.82[a](#jcla22989-note-0004){ref-type="fn"}   

  45792                                            4.20                                             4.18     0.47     0.67       (0.5)       6.00                     16.00[a](#jcla22989-note-0004){ref-type="fn"}   8.25[a](#jcla22989-note-0004){ref-type="fn"}    

  45793                                            7.77                                             7.70     0.91     0.82       (0.5)       6.00                     7.17[a](#jcla22989-note-0004){ref-type="fn"}    6.21[a](#jcla22989-note-0004){ref-type="fn"}    

  Ca                                               201811                                           2.10     2.08     0.82       2.38        (0.25)                   5.00                                            4.65[a](#jcla22989-note-0004){ref-type="fn"}    1.76^a,\ b^

  201812[c](#jcla22989-note-0006){ref-type="fn"}   2.34                                             2.33     0.65     2.14       (0.25)      5.00                     4.69[a](#jcla22989-note-0004){ref-type="fn"}    2.03^a,\ b^                                     

  45792[c](#jcla22989-note-0006){ref-type="fn"}    2.47                                             2.50     −1.39    1.66       (0.25)      5.00                     5.49[a](#jcla22989-note-0004){ref-type="fn"}    2.17^a, b^                                      

  45793                                            3.17                                             3.20     −1.00    1.55       (0.25)      5.00                     4.39[a](#jcla22989-note-0004){ref-type="fn"}    2.58^a, b^                                      

  Mg                                               201811                                           0.77     0.80     −3.99      3.90        25                       15.00                                           5.39                                            2.82[b](#jcla22989-note-0005){ref-type="fn"}

  201812[c](#jcla22989-note-0006){ref-type="fn"}   1.05                                             1.07     −1.96    1.90       25          15.00                    12.13                                           6.86                                            

  45792[c](#jcla22989-note-0006){ref-type="fn"}    1.11                                             1.09     2.12     1.98       25          15.00                    11.56                                           6.51                                            

  45793                                            1.75                                             1.74     0.96     1.82       25          15.00                    13.21                                           7.71                                            

  Cl                                               201811[c](#jcla22989-note-0006){ref-type="fn"}   95.20    95.19    0.01       0.40        5                        4.00                                            12.48                                           9.98

  201812                                           107.10                                           105.24   1.77     0.30       5           4.00                     10.77                                           7.43                                            

  45792[c](#jcla22989-note-0006){ref-type="fn"}    99.46                                            99.24    0.22     1.05       5           4.00                     4.55                                            3.60                                            

  45793                                            120.55                                           120.97   −0.34    1.19       5           4.00                     3.92                                            3.08                                            

  ALT                                              201801                                           35.70    37.70    −5.31      5.30        20                       16.00                                           2.77[b](#jcla22989-note-0005){ref-type="fn"}    2.02[b](#jcla22989-note-0005){ref-type="fn"}

  201802                                           62.90                                            67.40    −6.68    2.20       20          16.00                    6.05                                            4.24                                            

  201803[c](#jcla22989-note-0006){ref-type="fn"}   99.40                                            109.30   −9.06    1.70       20          16.00                    6.44                                            4.08                                            

  201804                                           153.60                                           169.40   −9.33    1.00       20          16.00                    10.67                                           6.67                                            

  201805                                           191.60                                           205.30   −6.67    1.00       20          16.00                    13.33                                           9.33                                            

  45792[c](#jcla22989-note-0006){ref-type="fn"}    93.17                                            95.55    −2.48    2.48       20          16.00                    7.06                                            5.45                                            

  45793                                            200.51                                           207.21   −3.24    1.71       20          16.00                    9.80                                            7.46                                            

  AST                                              201801                                           36.70    33.90    8.26       2.20        20                       15.00                                           5.34                                            3.06

  201802                                           73.00                                            70.10    4.14     1.00       20          15.00                    15.86                                           10.86                                           

  201803[c](#jcla22989-note-0006){ref-type="fn"}   108.40                                           105.20   3.04     1.30       20          15.00                    13.05                                           9.20                                            

  201804                                           173.50                                           167.40   3.64     0.60       20          15.00                    27.27                                           18.93                                           

  201805                                           202.20                                           199.70   1.25     0.80       20          15.00                    23.44                                           17.19                                           

  45792[c](#jcla22989-note-0006){ref-type="fn"}    111.36                                           114.25   −2.53    1.59       20          15.00                    10.99                                           7.84                                            

  45793                                            272.14                                           279.18   −2.52    1.43       20          15.00                    12.22                                           8.73                                            

  GGT                                              201801                                           44.50    49.00    −9.18      2.20        15                       11.00                                           2.65[b](#jcla22989-note-0005){ref-type="fn"}    0.83[b](#jcla22989-note-0005){ref-type="fn"}

  201802                                           74.00                                            77.32    −4.29    1.40       15          11.00                    7.65                                            4.79                                            

  201803[c](#jcla22989-note-0006){ref-type="fn"}   147.70                                           150.67   −1.97    0.60       15          11.00                    21.72                                           15.05                                           

  201804                                           194.00                                           194.55   −0.28    0.60       15          11.00                    24.53                                           17.87                                           

  201805                                           239.90                                           243.32   −1.41    0.80       15          11.00                    16.99                                           11.99                                           

  45792                                            85.37                                            87.23    −2.13    1.71       15          11.00                    7.53                                            5.19                                            

  45793[c](#jcla22989-note-0006){ref-type="fn"}    133.32                                           137.50   −3.04    1.52       15          11.00                    7.87                                            5.24                                            

  LDH                                              201801                                           155.30   157.16   −1.18      0.80        20                       11.00                                           23.53                                           12.28

  201802                                           196.90                                           197.55   −0.33    0.60       20          11.00                    32.78                                           17.78                                           

  201803                                           291.90                                           292.56   −0.23    0.70       20          11.00                    28.24                                           15.39                                           

  201804[c](#jcla22989-note-0006){ref-type="fn"}   411.90                                           421.00   −2.16    0.40       20          11.00                    44.60                                           22.10                                           

  201805                                           517.20                                           526.98   −1.86    0.70       20          11.00                    25.91                                           13.06                                           

  45792                                            176.88                                           177.43   −0.31    1.47       20          11.00                    13.39                                           7.27                                            

  45793[c](#jcla22989-note-0006){ref-type="fn"}    427.66                                           431.08   −0.79    1.09       20          11.00                    17.62                                           9.37                                            

  CK                                               201801                                           139.30   139.76   −0.33      0.90        30                       15.00                                           32.97                                           16.30

  201802                                           351.70                                           345.19   1.89     0.60       30          15.00                    46.85                                           21.85                                           

  201803[c](#jcla22989-note-0006){ref-type="fn"}   659.30                                           632.56   4.23     0.50       30          15.00                    51.54                                           21.54                                           

  201804                                           864.40                                           842.35   2.62     0.50       30          15.00                    54.76                                           24.76                                           

  201805                                           1147.20                                          112.84   3.09     0.70       30          15.00                    38.44                                           17.01                                           

  45792                                            254.45                                           257.41   −1.15    1.44       30          15.00                    20.03                                           9.62                                            

  45793[c](#jcla22989-note-0006){ref-type="fn"}    629.34                                           645.79   −2.55    2.52       30          15.00                    10.89                                           4.94                                            

  AMY                                              201801[c](#jcla22989-note-0006){ref-type="fn"}   124.00   118.00   5.08       0.90        30                       15.00                                           27.69                                           11.02

  201802                                           253.70                                           240.31   5.57     0.80       30          15.00                    30.54                                           11.79                                           

  201803                                           436.80                                           409.93   6.55     0.40       30          15.00                    58.63                                           21.13                                           

  201804                                           611.20                                           575.36   6.23     0.40       30          15.00                    59.43                                           21.93                                           

  201805                                           722.10                                           676.74   6.70     0.50       30          15.00                    46.60                                           16.60                                           

  45792[c](#jcla22989-note-0006){ref-type="fn"}    133.96                                           134.37   −0.31    1.81       30          18.00                    16.40                                           8.12                                            

  45793                                            285.64                                           289.69   −1.40    1.65       30          18.00                    17.33                                           8.24                                            

  ALP                                              201801                                           105.00   94.73    10.84      0.80        30                       18.00                                           23.95                                           8.95

  201802                                           260.90                                           241.75   7.92     0.60       30          18.00                    36.80                                           16.80                                           

  201803                                           454.80                                           402.41   13.02    0.60       30          18.00                    28.30                                           8.30                                            

  201804                                           541.60                                           487.27   11.15    0.40       30          18.00                    47.13                                           17.13                                           

  201805                                           635.90                                           580.86   9.48     0.70       30          18.00                    29.31                                           12.17                                           

  45792                                            138.54                                           141.77   −2.28    3.77       30          18.00                    7.35                                            4.17                                            

  45793                                            284.20                                           291.80   −2.60    2.40       30          18.00                    11.42                                           6.42                                            

  TC                                               201811                                           5.78     5.63     2.72       1.21        10                       9.00                                            6.02                                            5.19

  201812                                           3.72                                             3.61     2.96     1.08       10          9.00                     6.52                                            5.59                                            

  45792                                            4.32                                             4.21     2.51     1.41       10          9.00                     5.31                                            4.60                                            

  45793                                            7.72                                             7.69     0.32     1.10       10          9.00                     8.80                                            7.89                                            

  TG                                               201811                                           1.91     1.84     4.09       1.05        25                       14.00                                           19.91                                           9.44

  201812[c](#jcla22989-note-0006){ref-type="fn"}   1.30                                             1.23     5.69     1.54       25          14.00                    12.54                                           5.40                                            

  45792[c](#jcla22989-note-0006){ref-type="fn"}    1.54                                             1.49     3.50     2.06       25          14.00                    10.44                                           5.10                                            

  45793                                            4.92                                             4.81     2.17     1.10       25          14.00                    20.75                                           10.75                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ALP, alkaline phosphatase, U/L; ALT, alanine aminotransferase, U/L; AMY, amylase, U/L; AST, aspartate aminotransferase, U/L; Ca, calcium, mmol/L; CK, creatine kinase, U/L; Cl, chloride, mmol/L; CREA, creatinine, µmol/L; CV, coefficient of variation; GGT, gamma‐glutamyltransferase, U/L; GLU, glucose, mmol/L; K, potassium, mmol/L; LDH, lactate dehydrogenase, U/L; Mg, magnesium, mmol/L; Na, sodium, mmol/L; TC, total cholesterol, mmol/L; TEaCLIA, allowable total error derived from USA Clinical Laboratory Improvement Amendments of 1988 (CLIA \'88); TEaWS/T, allowable total error derived from the People\'s Republic of China Health Industry Standard (WS/T 403‐2012); TG, triglycerides, mmol/L; TP, total protein, g/L; UA, uric acid, µmol/L; UN, urea nitrogen, mmol/L.

σ is calculated by using absolute bias as the allowable total error (TEa), not marked indicates using percentage bias to calculate the σ.

σ \< 3.

σCLIA and σWS/T were compared at similar concentration levels for each assay using TPT‐based method and IQC‐based method.

John Wiley & Sons, Ltd

3. RESULTS {#jcla22989-sec-0013}
==========

3.1. Sigma metrics from TPT‐based approach {#jcla22989-sec-0014}
------------------------------------------

Sigma metrics of 19 assays computed by the TPT‐based approach and IQC‐based approach using two TEa requirements (σ~CLIA~ and σ~WS/T~) are listed in Table [2](#jcla22989-tbl-0002){ref-type="table"}. The TEa~CLIA~ used absolute bias for K, Na, and Ca assays, whereas TEa~WS/T~ used percentage bias and was stricter than TEa~CLIA~. Among the 19 assays by a TPT‐based approach, 16 assays showed σ~CLIA~ \> 3, 10 assays (GLU, CREA, K, Cl, LDH, CK, AMY, ALP, TC, and TG) showed σ~CLIA~ \> 6, and 3 assays (UN, ALT, and GGT) showed σ~CLIA~ \< 3. On the other hand, 12 assays showed σ~WS/T~ \> 3, 8 assays (CREA, Na, K, Cl, LDH, CK, AMY, and ALP) showed σ~WS/T~ \> 6, and 6 assays (UN, UA, Ca, Mg, ALT, and GGT) showed σ~WS/T~ \< 3. σ~CLIA~ \> σ~WS/T~ in 18 out of 19 assays (all except Na).

3.2. Sigma metrics from IQC‐based approach {#jcla22989-sec-0015}
------------------------------------------

Sigma metrics of 19 assays computed by the IQC‐based approach using two TEa requirements (σ~CLIA,~ σ~WS/T~) are shown in Table [2](#jcla22989-tbl-0002){ref-type="table"}. For the IQC‐based approach, 19 and 16 assays showed σ~CLIA~ \> 3 (GLU, CREA, UA, K, Mg, Cl, ALT, AST, GGT, LDH, CK, AMY, ALP, and TG exceeded 6σ levels) and σ~WS/T~ \> 3 (UA, Na, K, Mg, Cl, AST, LDH, AMY, ALP, TC, and TG exceeded 6σ levels), respectively. Similar to the TPT‐based approach, σ~CLIA~ \> σ~WS/T~ for all assays except Na.

3.3. Comparative analysis of sigma metrics between both methods {#jcla22989-sec-0016}
---------------------------------------------------------------

Nine analytes (GLU, CREA, K, Cl, LDH, CK, AMY, ALP, and TG) had a σ~CLIA~ above 6, and 6 analytes (Na, K, Cl, LDH, AMY, and ALP) had a σ~WS/T~ above 6 from both methods, which is actually effectively in agreement.

As shown in Figure [1](#jcla22989-fig-0001){ref-type="fig"}, the σ~CLIA~ and σ~WS/T~ derived from both methods for nineteen analytes were significantly different. For instance, the σ~CLIA~ for the TPT‐based approach vs the IQC‐based approach of UN at similar concentration levels was 12.46 (201912) versus 4.01 (45792), respectively, and similarly, the σ~WS/T~ was 10.70 (201912) vs 3.48 (45792), respectively. The σ~CLIA~ and σ~WS/T~ comparisons at similar concentration levels for both methods are shown in Table [2](#jcla22989-tbl-0002){ref-type="table"}.

![Comparison of σ~CLIA~ and σ~WS/T~ calculated using the trueness verification proficiency testing (TPT)‐based approach and the internal quality control data inter‐laboratory comparison (IQC)‐based approach for the same analyte. Note: solid lines are used for σ~CLIA~, and dashed lines are used for σ~WS/T~. 201801‐201805, 201811‐201812, and 201911‐201912 represent the lot numbers of trueness verification proficiency testing materials, and 45792 and 45793 represent the lot number of Bio‐Rad biochemistry quality control materials. ALP, alkaline phosphatase, U/L; ALT, alanine aminotransferase, U/L; AMY, amylase, U/L; AST, aspartate aminotransferase, U/L; Ca, calcium, mmol/L; CK, creatine kinase, U/L; Cl, chloride, mmol/L; CREA, creatinine, µmol/L; GGT, gamma‐glutamyltransferase, U/L; GLU, glucose, mmol/L; K, potassium, mmol/L; LDH, lactate dehydrogenase, U/L; Mg, magnesium, mmol/L; Na, sodium, mmol/L; TC, total cholesterol, mmol/L; TG, triglycerides, mmol/L; TP, total protein, g/L; UA, uric acid, µmol/L; UN, urea nitrogen, mmol/L](JCLA-33-na-g001){#jcla22989-fig-0001}

4. DISCUSSION {#jcla22989-sec-0017}
=============

Six Sigma and analytical sigma metrics are a widely accepted measure of assessing method quality, optimizing QC procedures, and processing improvement.[2](#jcla22989-bib-0002){ref-type="ref"}, [7](#jcla22989-bib-0007){ref-type="ref"} The sigma metrics computed at different concentration levels can be quite different from one another. Another challenge in calculating sigma metrics is how to acquire the appropriate TEa, bias, and CV (SD). Therefore, this study was introduced to explore the comparative analysis of sigma metrics computed by both methods.

There are different TEa quality requirements for routine chemistry,[20](#jcla22989-bib-0020){ref-type="ref"} and the optimal TEa quality requirements should be established depending on the conditions and requirements of the individual laboratory. At present, the first choice of TEa selection in China is the WS/T 403‐2012, which is the standard of the Ministry of Health published analytical quality specifications for routine clinical biochemistry in 2012. If the standard is too strict, other requirements, such as the CLIA\'88, the College of American Pathologists (CAP), guidelines of the German medical association for the quality assurance of laboratory medical examinations (RiliBÄK), and The Royal College of Pathologists of Australasia quality assurance programs (RCPA), could also be used.[2](#jcla22989-bib-0002){ref-type="ref"}, [20](#jcla22989-bib-0020){ref-type="ref"} If the TEa is too strict, the laboratory should assess the suitability of the TEa for clinical use or patient care and determine if that would allow a larger TEa choice. The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) published a recommended hierarchy for choosing an appropriate TEa whereby setting‐required performance specifications are based on 3 possible models: clinical outcomes, biological variabilities, and state‐of‐the‐art.[21](#jcla22989-bib-0021){ref-type="ref"} It provides a feasible model for standardizing protocols and is being introduced to encourage all laboratories to use the same quality goals for their sigma metrics benchmarks.[22](#jcla22989-bib-0022){ref-type="ref"} Because TEa~WS/T~ was more stringent than TEa~CLIA~ for the most analytes, the σ~WS/T~ was significantly lower than that of σ~CLIA~ in 18 out of 19 assays (all except Na). Therefore, the limitation of selecting an appropriate TEa requirement for σ calculation should be considered.

Bias is an estimate of systematic measurement error.[23](#jcla22989-bib-0023){ref-type="ref"} Assessing bias can be challenging, and bias evaluation can significantly impact the sigma metrics. Bias is always evaluated using the following methods.[8](#jcla22989-bib-0008){ref-type="ref"} (a) The optimal method is to compare results obtained from fresh human specimens using the measurement procedure and a reference measurement procedure. In this study, we used fresh frozen human serum samples provided by trueness verification proficiency testing program from the Chinese NCCL. The target means of nineteen analytes were determined using the corresponding reference measurement procedure from the Chinese NCCL. Samples derived from human serum could avoid the matrix effect, which was caused by the interaction of processed material and the measurement procedure and may suggest that erroneous results are being generated when in fact the results are acceptable.[24](#jcla22989-bib-0024){ref-type="ref"} The use of fresh frozen human specimens could avoid the matrix‐related bias.[25](#jcla22989-bib-0025){ref-type="ref"} (b) Another way to assess relative bias is by comparing laboratory results with the statistical mean of the peer group using the same instrument and method from inter‐laboratory QC data or proficiency testing (PT)/external quality assessment (EQA) reports. Because the target means in PT/EQA programs were derived from statistical results without measurement traceability,[15](#jcla22989-bib-0015){ref-type="ref"}, [26](#jcla22989-bib-0026){ref-type="ref"}, [27](#jcla22989-bib-0027){ref-type="ref"} those using this approach should be aware of the possible limitations, including statistical methods used to generate the data and the number of laboratories that participate.[23](#jcla22989-bib-0023){ref-type="ref"}

Imprecision is typically expressed as an SD or CV. The imprecision estimation for sigma metrics should be based on results from a sufficient duration of time to adequately represent the types of influences, such as a periodic recalibration, changes in bottles of reagents, changes in lots of reagents or calibrators, and maintenance procedures. We used six months of IQC data to obtain relatively stable results. By contrast, the TPT‐based approach may lead to a lower CV and an overestimated σ value because of the short‐term assessment.[15](#jcla22989-bib-0015){ref-type="ref"}

We further studied the QC rule design based on the sigma metrics of nineteen analytes designed based on sigma metrics by both methods using two TEa standards (data not shown in this study). The differences in QC rules, QC numbers, and QC run sizes as calculated using both approaches and two TEa standards were analyzed. The QC setting of nineteen analytes was compared test by test, that of seven analytes were the same and twelve analytes were different. QC rules based on TEa~ws/t~ were more stringent than that based on TEa~CLIA~. We are working on the adjustment of the individualized QC plan of the analyte based on its sigma metric evaluation.

One weakness of this study is that the imprecision evaluation following the Chinese NCCL instruction by the TPT approach (analyze five replicate samples at each of different concentrations daily for 3 days to obtain 15 results) was not conducted strictly according to the method described in the CLSI guideline EP15‐A2 document (analyze one run per day with 3 replicate samples at each of different concentrations daily for 5 days to obtain 15 results) and CLSI guideline EP5‐A3 (analyze two replicate samples at each of different concentrations daily for 20 days to obtain 40 results).[28](#jcla22989-bib-0028){ref-type="ref"} The TPT approach only lasted 3 days, which may have underestimated the imprecision.[18](#jcla22989-bib-0018){ref-type="ref"} The numbers of laboratories for the Bio‐Rad IQC method from peer group comparison ranged between 5 and 50, and there may be increased imprecision due to the small number of laboratories. The concentration of analytes of the IQC materials differed significantly from that of the TPT samples, which may contribute to the differences in the calculation of σ based on both methods. Moreover, the research results may encourage the application of different methods for sigma evaluation, without the cost of high maintenance of commercial QC materials.

In conclusion, a combination of the TPT‐based and IQC‐based approach using NCCL and CLIA TEa goals may be adopted as the useful approaches for sigma metrics evaluation in clinical laboratories. When applying sigma metrics for Six Sigma management or quality control, sigma metrics should be evaluated comprehensively by different approaches.
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